Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
0.0148
-0.0002 (-1.33%)
Jan 21, 2026, 3:52 PM CET
-89.69% (1Y)
| Market Cap | 9.09M |
| Revenue (ttm) | 1.32M |
| Net Income (ttm) | -35.97M |
| Shares Out | 605.93M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 747,830 |
| Average Volume | 6,561,859 |
| Open | 0.0150 |
| Previous Close | 0.0150 |
| Day's Range | 0.0128 - 0.0160 |
| 52-Week Range | 0.0072 - 0.3695 |
| Beta | 0.60 |
| RSI | 32.94 |
| Earnings Date | Feb 20, 2026 |